Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03114865
What this trial is testing

Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Testing effectiveness (Phase 2)Study completedNCT00253513
What this trial is testing

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
OHSU Knight Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Early research (Phase 1)Looking for participantsNCT06543381
What this trial is testing

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT04099966
What this trial is testing

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Who this might be right for
Acute LeukemiaSevere Aplastic AnemiaNon-hodgkin Lymphoma+6 more
Mitchell Cairo 20
Testing effectiveness (Phase 2)Ended earlyNCT03615105
What this trial is testing

Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

Who this might be right for
Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)+3 more
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Testing effectiveness (Phase 2)Study completedNCT02472691
What this trial is testing

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT00223730
What this trial is testing

Chemotherapy Toxicity Reduction Via Urea Cycle Support

Who this might be right for
Cancer
Vanderbilt University 100
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Not applicableStudy completedNCT00186290
What this trial is testing

Allo BMT in Advanced Leukemia or High Grade Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLeukemiaBlood and Marrow Transplant (BMT)+1 more
Stanford University 145
Testing effectiveness (Phase 2)Study completedNCT00004143
What this trial is testing

Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes

Who this might be right for
Sickle Cell AnemiaSevere Aplastic AnemiaParoxysmal Nocturnal Hemoglobinuria (PNH)+1 more
David Rizzieri, MD 2
Not applicableStudy completedNCT01929408
What this trial is testing

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Fred Hutchinson Cancer Center 703
Testing effectiveness (Phase 2)Study completedNCT01487577
What this trial is testing

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Who this might be right for
Allogeneic Blood and Marrow Transplantation (BMT)Graft Versus Host Disease
University of Pittsburgh 19
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01068301
What this trial is testing

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+2 more
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT01795677
What this trial is testing

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
French Innovative Leukemia Organisation 78
Testing effectiveness (Phase 2)Ended earlyNCT04762875
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Who this might be right for
Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous Leukemia+2 more
Ensoma 7
Testing effectiveness (Phase 2)Study completedNCT00070135
What this trial is testing

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Alliance for Clinical Trials in Oncology 121
Next Page